Concepedia

Ismail Mitha

IM

Statistics

Publications

19

Citations

6K

H-Index

14

Active since

2008

Affiliations

University of the Witwatersrand(Current)

Oregon Health & Science University

National Health Laboratory Service

Indiana Hemophilia and Thrombosis Center

University of Toronto

Ismail Mitha is an author at University of the Witwatersrand specializing in pharmacology, clinical pharmacology, and medicine.

Publications per year

2008–2023

19

Publications

19

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes

Michael A. Nauck, Anders Frid, Kjeld Hermansen et al. · Diabetes Care · 2008 · 1.1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Omadacycline for Community-Acquired Bacterial Pneumonia

Roman Stets, Monica Popescu, Joven Gonong et al. · New England Journal of Medicine · 2019 · 229 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

Deepak L. Bhatt, Philippe Gabríel Steg, Shamir R Mehta et al. · The Lancet · 2019 · 210 citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

1–5 of 19